

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.52822419 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 7.67066431 |
| 3 | vitamin A metabolic process (GO:0006776) | 6.62585111 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 6.37523247 |
| 5 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.33992495 |
| 6 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.23341630 |
| 7 | actin filament depolymerization (GO:0030042) | 6.12002891 |
| 8 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 6.03126490 |
| 9 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.85286532 |
| 10 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.85286532 |
| 11 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.77772873 |
| 12 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.76676437 |
| 13 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.72260163 |
| 14 | digestive system process (GO:0022600) | 5.64496998 |
| 15 | sulfate transmembrane transport (GO:1902358) | 5.61800779 |
| 16 | flavonoid metabolic process (GO:0009812) | 5.61139269 |
| 17 | fructose metabolic process (GO:0006000) | 5.51707057 |
| 18 | regulation of bile acid biosynthetic process (GO:0070857) | 5.43611578 |
| 19 | adhesion of symbiont to host cell (GO:0044650) | 5.37262507 |
| 20 | virion attachment to host cell (GO:0019062) | 5.37262507 |
| 21 | regulation of cellular extravasation (GO:0002691) | 5.32255574 |
| 22 | bile acid and bile salt transport (GO:0015721) | 5.24883550 |
| 23 | intestinal epithelial cell development (GO:0060576) | 5.10934418 |
| 24 | drug catabolic process (GO:0042737) | 4.92129319 |
| 25 | drug metabolic process (GO:0017144) | 4.70032762 |
| 26 | regulation of cGMP biosynthetic process (GO:0030826) | 4.65405457 |
| 27 | sulfate transport (GO:0008272) | 4.61350485 |
| 28 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.55687785 |
| 29 | response to hepatocyte growth factor (GO:0035728) | 4.55687785 |
| 30 | digestion (GO:0007586) | 4.51415926 |
| 31 | glucose 6-phosphate metabolic process (GO:0051156) | 4.49975388 |
| 32 | urea cycle (GO:0000050) | 4.44838445 |
| 33 | renal system process involved in regulation of blood volume (GO:0001977) | 4.37630457 |
| 34 | epithelial structure maintenance (GO:0010669) | 4.35682453 |
| 35 | O-glycan processing (GO:0016266) | 4.33946339 |
| 36 | phospholipid efflux (GO:0033700) | 4.32411450 |
| 37 | cellular glucuronidation (GO:0052695) | 4.30867949 |
| 38 | sulfation (GO:0051923) | 4.28379285 |
| 39 | adhesion of symbiont to host (GO:0044406) | 4.27438513 |
| 40 | glucuronate metabolic process (GO:0019585) | 4.25810653 |
| 41 | uronic acid metabolic process (GO:0006063) | 4.25810653 |
| 42 | modified amino acid transport (GO:0072337) | 4.24630561 |
| 43 | urea metabolic process (GO:0019627) | 4.23885782 |
| 44 | sulfur compound transport (GO:0072348) | 4.19288245 |
| 45 | plasma lipoprotein particle assembly (GO:0034377) | 4.16805164 |
| 46 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.16729039 |
| 47 | positive regulation of pseudopodium assembly (GO:0031274) | 4.09712954 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 4.06208164 |
| 49 | glycolipid catabolic process (GO:0019377) | 4.02871943 |
| 50 | protein-lipid complex assembly (GO:0065005) | 4.02855640 |
| 51 | bicarbonate transport (GO:0015701) | 4.02384193 |
| 52 | hormone catabolic process (GO:0042447) | 4.01030752 |
| 53 | glycosphingolipid catabolic process (GO:0046479) | 4.00463548 |
| 54 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.00450038 |
| 55 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.00450038 |
| 56 | sperm capacitation (GO:0048240) | 3.99246847 |
| 57 | lipoprotein metabolic process (GO:0042157) | 3.97634553 |
| 58 | nitrogen cycle metabolic process (GO:0071941) | 3.90970870 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 3.86378613 |
| 60 | regulation of cGMP metabolic process (GO:0030823) | 3.85297168 |
| 61 | vitamin transmembrane transport (GO:0035461) | 3.77238781 |
| 62 | regulation of cholesterol homeostasis (GO:2000188) | 3.70446736 |
| 63 | cellular response to nitric oxide (GO:0071732) | 3.69556903 |
| 64 | peptide hormone processing (GO:0016486) | 3.68575120 |
| 65 | regulation of pseudopodium assembly (GO:0031272) | 3.66706442 |
| 66 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.66493600 |
| 67 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.66074584 |
| 68 | transcytosis (GO:0045056) | 3.62531666 |
| 69 | lipoprotein transport (GO:0042953) | 3.62275529 |
| 70 | cholesterol homeostasis (GO:0042632) | 3.61890365 |
| 71 | diacylglycerol metabolic process (GO:0046339) | 3.60195771 |
| 72 | sterol homeostasis (GO:0055092) | 3.59043423 |
| 73 | negative regulation of cholesterol transport (GO:0032375) | 3.56588284 |
| 74 | negative regulation of sterol transport (GO:0032372) | 3.56588284 |
| 75 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.55482823 |
| 76 | positive regulation of respiratory burst (GO:0060267) | 3.55073826 |
| 77 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.55067987 |
| 78 | homocysteine metabolic process (GO:0050667) | 3.53625749 |
| 79 | peptide catabolic process (GO:0043171) | 3.51168059 |
| 80 | cholesterol efflux (GO:0033344) | 3.49233040 |
| 81 | striated muscle atrophy (GO:0014891) | 3.47698602 |
| 82 | vitamin transport (GO:0051180) | 3.47093552 |
| 83 | antibacterial humoral response (GO:0019731) | 3.45771916 |
| 84 | transepithelial transport (GO:0070633) | 3.44678757 |
| 85 | cGMP-mediated signaling (GO:0019934) | 3.43953889 |
| 86 | response to nitric oxide (GO:0071731) | 3.43125582 |
| 87 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.42386604 |
| 88 | antimicrobial humoral response (GO:0019730) | 3.42321770 |
| 89 | drinking behavior (GO:0042756) | 3.41883990 |
| 90 | thyroid hormone metabolic process (GO:0042403) | 3.41735532 |
| 91 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41337004 |
| 92 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.36441752 |
| 93 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.33182479 |
| 94 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.33110717 |
| 95 | arginine metabolic process (GO:0006525) | 3.32736778 |
| 96 | hepatocyte apoptotic process (GO:0097284) | 3.32431700 |
| 97 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.32297073 |
| 98 | fat-soluble vitamin metabolic process (GO:0006775) | 3.31070908 |
| 99 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.30726016 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.29321449 |
| 101 | regulation of actin nucleation (GO:0051125) | 3.27984354 |
| 102 | cholesterol transport (GO:0030301) | 3.27668961 |
| 103 | sterol transport (GO:0015918) | 3.27668961 |
| 104 | cellular response to reactive nitrogen species (GO:1902170) | 3.26882357 |
| 105 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.25318404 |
| 106 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.24725435 |
| 107 | ceramide catabolic process (GO:0046514) | 3.21263624 |
| 108 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.20162668 |
| 109 | endocrine process (GO:0050886) | 3.20162668 |
| 110 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.20162668 |
| 111 | sexual reproduction (GO:0019953) | 3.19895750 |
| 112 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.18177447 |
| 113 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.15762476 |
| 114 | thrombin receptor signaling pathway (GO:0070493) | 3.15286229 |
| 115 | hemidesmosome assembly (GO:0031581) | 3.13420528 |
| 116 | cGMP biosynthetic process (GO:0006182) | 3.12459384 |
| 117 | glycosylceramide metabolic process (GO:0006677) | 3.11758468 |
| 118 | regulation of viral release from host cell (GO:1902186) | 3.10417723 |
| 119 | bile acid metabolic process (GO:0008206) | 3.09634658 |
| 120 | glycerol metabolic process (GO:0006071) | 3.07977212 |
| 121 | midgut development (GO:0007494) | 3.07667383 |
| 122 | positive regulation of lipid catabolic process (GO:0050996) | 3.07594267 |
| 123 | sphingolipid catabolic process (GO:0030149) | 3.06970294 |
| 124 | vitamin biosynthetic process (GO:0009110) | 3.06410870 |
| 125 | alkaloid metabolic process (GO:0009820) | 3.04432160 |
| 126 | desmosome organization (GO:0002934) | 3.04180991 |
| 127 | leukotriene metabolic process (GO:0006691) | 3.03583909 |
| 128 | glomerular filtration (GO:0003094) | 3.03063800 |
| 129 | oligosaccharide catabolic process (GO:0009313) | 3.01560085 |
| 130 | sphingomyelin metabolic process (GO:0006684) | 3.01349467 |
| 131 | skeletal muscle adaptation (GO:0043501) | 3.01307731 |
| 132 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.00437288 |
| 133 | cytidine metabolic process (GO:0046087) | 2.98233334 |
| 134 | cytidine catabolic process (GO:0006216) | 2.98233334 |
| 135 | cytidine deamination (GO:0009972) | 2.98233334 |
| 136 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.96111147 |
| 137 | regulation of vitamin metabolic process (GO:0030656) | 2.90997855 |
| 138 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.90623339 |
| 139 | epithelial cell-cell adhesion (GO:0090136) | 2.89206390 |
| 140 | exogenous drug catabolic process (GO:0042738) | 2.87824181 |
| 141 | muscle atrophy (GO:0014889) | 2.87287081 |
| 142 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.86992588 |
| 143 | regulation of systemic arterial blood pressure (GO:0003073) | 2.86971009 |
| 144 | protein-lipid complex remodeling (GO:0034368) | 2.86733433 |
| 145 | macromolecular complex remodeling (GO:0034367) | 2.86733433 |
| 146 | plasma lipoprotein particle remodeling (GO:0034369) | 2.86733433 |
| 147 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.85309865 |
| 148 | nucleotide-sugar metabolic process (GO:0009225) | 2.83694660 |
| 149 | NADH metabolic process (GO:0006734) | 2.81638580 |
| 150 | drug transport (GO:0015893) | 2.81041777 |
| 151 | protein-lipid complex subunit organization (GO:0071825) | 2.78780441 |
| 152 | intestinal absorption (GO:0050892) | 11.5429678 |
| 153 | intestinal cholesterol absorption (GO:0030299) | 10.1629898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.32437810 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.73195780 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.97021686 |
| 4 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.13118026 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.06763526 |
| 6 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.96254056 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.80317787 |
| 8 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.79524604 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.75313466 |
| 10 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.68434745 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.45034502 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.44197512 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.43098760 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24442412 |
| 15 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.17537166 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.13425834 |
| 17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.10962915 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.06945930 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.98132907 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97090406 |
| 21 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.92724502 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81692448 |
| 23 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.80994701 |
| 24 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.80175764 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.78771333 |
| 26 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.73926413 |
| 27 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.71866926 |
| 28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.69263700 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69000925 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68707474 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.68265575 |
| 32 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67406541 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.64120763 |
| 34 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62772426 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61774096 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.61725686 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.59617156 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.59143650 |
| 39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56762216 |
| 40 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.54576180 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49216085 |
| 42 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.48305051 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45609319 |
| 44 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42754936 |
| 45 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40781342 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40503755 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38193782 |
| 48 | ATF3_27146783_Chip-Seq_COLON_Human | 1.38005343 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36659863 |
| 50 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32873905 |
| 51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32593554 |
| 52 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.26617528 |
| 53 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26189423 |
| 54 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25830599 |
| 55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20854616 |
| 56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18574451 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18066750 |
| 58 | SA1_27219007_Chip-Seq_Bcells_Human | 1.16578853 |
| 59 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16029217 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16004490 |
| 61 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.15446626 |
| 62 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.15212160 |
| 63 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.13759354 |
| 64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13038396 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13028418 |
| 66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12147304 |
| 67 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10649119 |
| 68 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.10406817 |
| 69 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10277047 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09471625 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09163863 |
| 72 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08130205 |
| 73 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07197025 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06900116 |
| 75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05613578 |
| 76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05483335 |
| 77 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05307900 |
| 78 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.04586963 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02473637 |
| 80 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01215742 |
| 81 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01113352 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99409337 |
| 83 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99409337 |
| 84 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.99292294 |
| 85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98911611 |
| 86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98697924 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98018799 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97880515 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97134352 |
| 90 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96625672 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96575658 |
| 92 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94994259 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94717024 |
| 94 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94669808 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94573777 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93645490 |
| 97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93066355 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92939227 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92864609 |
| 100 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.91857994 |
| 101 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.90637297 |
| 102 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.87453983 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87234758 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87047821 |
| 105 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87025582 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86901048 |
| 107 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85354759 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84989937 |
| 109 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84910027 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84695641 |
| 111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84230104 |
| 112 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.84198671 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83945121 |
| 114 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82834774 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82684343 |
| 116 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82515832 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82142283 |
| 118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82105262 |
| 119 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81630428 |
| 120 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81578129 |
| 121 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80389083 |
| 122 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.79805606 |
| 123 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.79139201 |
| 124 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.78979725 |
| 125 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.78106451 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77874753 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77773089 |
| 128 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77632288 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77539428 |
| 130 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.77102650 |
| 131 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75388180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.77875938 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.72389773 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 5.37055497 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 4.05230149 |
| 5 | MP0000462_abnormal_digestive_system | 3.70776181 |
| 6 | MP0003866_abnormal_defecation | 3.59153995 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.18416377 |
| 8 | MP0003183_abnormal_peptide_metabolism | 3.07975435 |
| 9 | MP0009840_abnormal_foam_cell | 2.97692012 |
| 10 | MP0002822_catalepsy | 2.79976958 |
| 11 | MP0003252_abnormal_bile_duct | 2.77990584 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.74963309 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.68956176 |
| 14 | MP0003283_abnormal_digestive_organ | 2.43466018 |
| 15 | MP0001873_stomach_inflammation | 2.40560551 |
| 16 | MP0005377_hearing/vestibular/ear_phenot | 2.37379551 |
| 17 | MP0003878_abnormal_ear_physiology | 2.37379551 |
| 18 | MP0001663_abnormal_digestive_system | 2.34262740 |
| 19 | MP0010155_abnormal_intestine_physiology | 2.33489121 |
| 20 | MP0005381_digestive/alimentary_phenotyp | 2.32303387 |
| 21 | MP0005409_darkened_coat_color | 2.24169024 |
| 22 | MP0000537_abnormal_urethra_morphology | 2.23141134 |
| 23 | MP0001664_abnormal_digestion | 2.22745312 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.10165431 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 2.09779862 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.04288478 |
| 27 | MP0005365_abnormal_bile_salt | 2.02515823 |
| 28 | MP0000490_abnormal_crypts_of | 1.94608381 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.88645085 |
| 30 | * MP0000477_abnormal_intestine_morphology | 1.88332799 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.80748085 |
| 32 | MP0004147_increased_porphyrin_level | 1.80724860 |
| 33 | MP0000538_abnormal_urinary_bladder | 1.72855992 |
| 34 | MP0004043_abnormal_pH_regulation | 1.60393883 |
| 35 | MP0005670_abnormal_white_adipose | 1.47990601 |
| 36 | MP0005084_abnormal_gallbladder_morpholo | 1.45669991 |
| 37 | MP0002796_impaired_skin_barrier | 1.40321293 |
| 38 | MP0001188_hyperpigmentation | 1.39268597 |
| 39 | MP0004858_abnormal_nervous_system | 1.38902571 |
| 40 | MP0006054_spinal_hemorrhage | 1.38754423 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.36962272 |
| 42 | MP0005448_abnormal_energy_balance | 1.25343914 |
| 43 | MP0003868_abnormal_feces_composition | 1.23687972 |
| 44 | MP0004782_abnormal_surfactant_physiolog | 1.22819842 |
| 45 | MP0001849_ear_inflammation | 1.21645934 |
| 46 | MP0010678_abnormal_skin_adnexa | 1.20449209 |
| 47 | MP0009053_abnormal_anal_canal | 1.17214588 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.16119534 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.12497048 |
| 50 | MP0003315_abnormal_perineum_morphology | 1.09398209 |
| 51 | MP0001765_abnormal_ion_homeostasis | 1.09182257 |
| 52 | MP0009379_abnormal_foot_pigmentation | 1.07837063 |
| 53 | MP0004947_skin_inflammation | 1.06879424 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 1.05870745 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.03203233 |
| 56 | MP0002254_reproductive_system_inflammat | 1.02984468 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.02497545 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.02452681 |
| 59 | MP0008004_abnormal_stomach_pH | 1.02422565 |
| 60 | MP0000467_abnormal_esophagus_morphology | 0.97779195 |
| 61 | MP0002971_abnormal_brown_adipose | 0.94236757 |
| 62 | MP0005535_abnormal_body_temperature | 0.91252884 |
| 63 | MP0005367_renal/urinary_system_phenotyp | 0.91135158 |
| 64 | MP0000516_abnormal_urinary_system | 0.91135158 |
| 65 | MP0002098_abnormal_vibrissa_morphology | 0.88131790 |
| 66 | MP0000470_abnormal_stomach_morphology | 0.86703060 |
| 67 | MP0009785_altered_susceptibility_to | 0.86582727 |
| 68 | MP0002118_abnormal_lipid_homeostasis | 0.86375140 |
| 69 | MP0005501_abnormal_skin_physiology | 0.86120986 |
| 70 | MP0004270_analgesia | 0.85964036 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 0.85918331 |
| 72 | MP0008872_abnormal_physiological_respon | 0.85709803 |
| 73 | MP0000230_abnormal_systemic_arterial | 0.85360684 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.84677587 |
| 75 | MP0003724_increased_susceptibility_to | 0.84207914 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 0.83468851 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.83222774 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 0.82222796 |
| 79 | MP0005310_abnormal_salivary_gland | 0.81476880 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.81003916 |
| 81 | MP0009384_cardiac_valve_regurgitation | 0.80145988 |
| 82 | MP0005166_decreased_susceptibility_to | 0.79995362 |
| 83 | MP0000609_abnormal_liver_physiology | 0.79460591 |
| 84 | MP0001835_abnormal_antigen_presentation | 0.78095975 |
| 85 | MP0008469_abnormal_protein_level | 0.74336216 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.74039553 |
| 87 | MP0005332_abnormal_amino_acid | 0.73277588 |
| 88 | MP0005025_abnormal_response_to | 0.72618730 |
| 89 | MP0003303_peritoneal_inflammation | 0.72437433 |
| 90 | MP0005451_abnormal_body_composition | 0.71746959 |
| 91 | MP0003436_decreased_susceptibility_to | 0.71554330 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.68043209 |
| 93 | MP0001216_abnormal_epidermal_layer | 0.67865416 |
| 94 | MP0003879_abnormal_hair_cell | 0.67442696 |
| 95 | MP0001485_abnormal_pinna_reflex | 0.67041628 |
| 96 | MP0000604_amyloidosis | 0.65162170 |
| 97 | MP0005387_immune_system_phenotype | 0.64174088 |
| 98 | MP0001790_abnormal_immune_system | 0.64174088 |
| 99 | MP0003329_amyloid_beta_deposits | 0.63859791 |
| 100 | MP0006082_CNS_inflammation | 0.62800715 |
| 101 | MP0005266_abnormal_metabolism | 0.62140894 |
| 102 | MP0000613_abnormal_salivary_gland | 0.61795655 |
| 103 | MP0000249_abnormal_blood_vessel | 0.61376910 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.60647774 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.59270424 |
| 106 | MP0009333_abnormal_splenocyte_physiolog | 0.58324530 |
| 107 | MP0009764_decreased_sensitivity_to | 0.56127957 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.55991932 |
| 109 | MP0003045_fibrosis | 0.53993146 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.53658321 |
| 111 | MP0000678_abnormal_parathyroid_gland | 0.52943106 |
| 112 | MP0001881_abnormal_mammary_gland | 0.50791921 |
| 113 | MP0003718_maternal_effect | 0.50414236 |
| 114 | MP0002006_tumorigenesis | 0.50084279 |
| 115 | MP0005334_abnormal_fat_pad | 0.49470281 |
| 116 | MP0005174_abnormal_tail_pigmentation | 0.48686561 |
| 117 | MP0002148_abnormal_hypersensitivity_rea | 0.48004153 |
| 118 | MP0000566_synostosis | 0.46610108 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.46447034 |
| 120 | MP0001756_abnormal_urination | 0.46293486 |
| 121 | MP0009697_abnormal_copulation | 0.46067780 |
| 122 | MP0000377_abnormal_hair_follicle | 0.45380025 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.42723594 |
| 124 | MP0008873_increased_physiological_sensi | 0.40894064 |
| 125 | MP0001191_abnormal_skin_condition | 0.39890657 |
| 126 | MP0001764_abnormal_homeostasis | 0.39600612 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.39590845 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.39194218 |
| 129 | MP0003693_abnormal_embryo_hatching | 0.39146123 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.38543475 |
| 131 | MP0002060_abnormal_skin_morphology | 0.36802433 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.36188077 |
| 133 | MP0004484_altered_response_of | 0.35112103 |
| 134 | MP0010771_integument_phenotype | 0.34287726 |
| 135 | MP0009115_abnormal_fat_cell | 0.34254515 |
| 136 | MP0005023_abnormal_wound_healing | 0.34073215 |
| 137 | MP0003950_abnormal_plasma_membrane | 0.33804999 |
| 138 | MP0005666_abnormal_adipose_tissue | 0.33746615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 9.08460137 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 5.96591141 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.72740731 |
| 4 | Acanthocytosis (HP:0001927) | 5.54086952 |
| 5 | Malnutrition (HP:0004395) | 5.24283106 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.09869449 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 4.80669072 |
| 8 | Abdominal distention (HP:0003270) | 4.52261424 |
| 9 | Cupped ribs (HP:0000887) | 4.48555306 |
| 10 | Flat acetabular roof (HP:0003180) | 4.42104770 |
| 11 | Chronic diarrhea (HP:0002028) | 4.40392640 |
| 12 | Confusion (HP:0001289) | 4.35574285 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.34125105 |
| 14 | Abnormality of proline metabolism (HP:0010907) | 4.29541080 |
| 15 | Hydroxyprolinuria (HP:0003080) | 4.29541080 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.92509847 |
| 17 | Abnormality of the 1st metacarpal (HP:0010009) | 3.79858668 |
| 18 | Decreased circulating renin level (HP:0003351) | 3.71073513 |
| 19 | Fat malabsorption (HP:0002630) | 3.70211868 |
| 20 | Nausea (HP:0002018) | 3.56241413 |
| 21 | Gastrointestinal dysmotility (HP:0002579) | 3.40034120 |
| 22 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.38594398 |
| 23 | Widely patent fontanelles and sutures (HP:0004492) | 3.28034628 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 3.25671868 |
| 25 | Hyperactive renin-angiotensin system (HP:0000841) | 3.25491126 |
| 26 | Alkalosis (HP:0001948) | 3.23774668 |
| 27 | Proximal tubulopathy (HP:0000114) | 3.22954212 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.16192291 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.16192291 |
| 30 | Poikilocytosis (HP:0004447) | 3.15743401 |
| 31 | Pigmentary retinal degeneration (HP:0001146) | 3.15148649 |
| 32 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.07953171 |
| 33 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.03297174 |
| 34 | Abnormality of renin-angiotensin system (HP:0000847) | 3.02474630 |
| 35 | Dehydration (HP:0001944) | 3.00647742 |
| 36 | Hypolipoproteinemia (HP:0010981) | 2.97031307 |
| 37 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.93710867 |
| 38 | Villous atrophy (HP:0011473) | 2.93710867 |
| 39 | Hyperuricemia (HP:0002149) | 2.92201469 |
| 40 | Increased purine levels (HP:0004368) | 2.92201469 |
| 41 | Progressive sensorineural hearing impairment (HP:0000408) | 2.87523675 |
| 42 | Hypophosphatemia (HP:0002148) | 2.85882386 |
| 43 | Abnormal tarsal ossification (HP:0008369) | 2.83797669 |
| 44 | Abnormality of chloride homeostasis (HP:0011422) | 2.81930683 |
| 45 | Woolly hair (HP:0002224) | 2.81809451 |
| 46 | Rectal prolapse (HP:0002035) | 2.81614715 |
| 47 | Abnormal biliary tract morphology (HP:0012440) | 2.81502759 |
| 48 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.81080296 |
| 49 | Metabolic alkalosis (HP:0200114) | 2.80325840 |
| 50 | Abnormality of vitamin B metabolism (HP:0004340) | 2.80141588 |
| 51 | Pustule (HP:0200039) | 2.78706926 |
| 52 | Hemorrhage of the eye (HP:0011885) | 2.78153418 |
| 53 | Megaloblastic anemia (HP:0001889) | 2.77905336 |
| 54 | Eczematoid dermatitis (HP:0000976) | 2.75908282 |
| 55 | Steatorrhea (HP:0002570) | 2.69901188 |
| 56 | Palpitations (HP:0001962) | 2.64011573 |
| 57 | Hyperammonemia (HP:0001987) | 2.60310394 |
| 58 | Short phalanx of the thumb (HP:0009660) | 2.59551703 |
| 59 | Abnormality of urine glucose concentration (HP:0011016) | 2.58022388 |
| 60 | Glycosuria (HP:0003076) | 2.58022388 |
| 61 | Facial shape deformation (HP:0011334) | 2.56903277 |
| 62 | Potter facies (HP:0002009) | 2.56903277 |
| 63 | Enlarged epiphyses (HP:0010580) | 2.55877514 |
| 64 | Syncope (HP:0001279) | 2.55059269 |
| 65 | Abnormality of carpal bone ossification (HP:0006257) | 2.54551771 |
| 66 | Flattened epiphyses (HP:0003071) | 2.53485688 |
| 67 | Milia (HP:0001056) | 2.53481403 |
| 68 | Pili torti (HP:0003777) | 2.53158929 |
| 69 | Abnormality of the gastric mucosa (HP:0004295) | 2.51115503 |
| 70 | Hypotension (HP:0002615) | 2.50181424 |
| 71 | Focal segmental glomerulosclerosis (HP:0000097) | 2.47828943 |
| 72 | Intrahepatic cholestasis (HP:0001406) | 2.47413382 |
| 73 | Fragile nails (HP:0001808) | 2.44792669 |
| 74 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.44760977 |
| 75 | Congenital sensorineural hearing impairment (HP:0008527) | 2.44720124 |
| 76 | Neonatal short-limb short stature (HP:0008921) | 2.43894094 |
| 77 | Hyperglycinuria (HP:0003108) | 2.43314444 |
| 78 | Delayed epiphyseal ossification (HP:0002663) | 2.43243729 |
| 79 | Progressive hearing impairment (HP:0001730) | 2.42809222 |
| 80 | Abnormal urine phosphate concentration (HP:0012599) | 2.38817616 |
| 81 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.37216362 |
| 82 | Micronodular cirrhosis (HP:0001413) | 2.35629076 |
| 83 | Abnormality of vitamin metabolism (HP:0100508) | 2.31688616 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.30520848 |
| 85 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.29061320 |
| 86 | Mesangial abnormality (HP:0001966) | 2.26751771 |
| 87 | Abnormality of the costochondral junction (HP:0000919) | 2.26598252 |
| 88 | Biliary tract neoplasm (HP:0100574) | 2.25610334 |
| 89 | Glomerulonephritis (HP:0000099) | 2.25101987 |
| 90 | Abnormal foot bone ossification (HP:0010675) | 2.24881470 |
| 91 | Bundle branch block (HP:0011710) | 2.24706602 |
| 92 | Hyperparathyroidism (HP:0000843) | 2.23881270 |
| 93 | Hoarse voice (HP:0001609) | 2.19993391 |
| 94 | Nephrolithiasis (HP:0000787) | 2.17634459 |
| 95 | Abnormal glucose tolerance (HP:0001952) | 2.17241935 |
| 96 | Protuberant abdomen (HP:0001538) | 2.17010307 |
| 97 | Xanthomatosis (HP:0000991) | 2.16753525 |
| 98 | Vertebral clefting (HP:0008428) | 2.14433012 |
| 99 | Increased IgE level (HP:0003212) | 2.13485061 |
| 100 | Abnormality of complement system (HP:0005339) | 2.13319325 |
| 101 | Hyperphosphatemia (HP:0002905) | 2.13065300 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 2.12008756 |
| 103 | Gout (HP:0001997) | 2.11660570 |
| 104 | Subcapsular cataract (HP:0000523) | 2.11487554 |
| 105 | Posterior subcapsular cataract (HP:0007787) | 2.10339584 |
| 106 | Gingivitis (HP:0000230) | 2.10021236 |
| 107 | Metabolic acidosis (HP:0001942) | 2.08802946 |
| 108 | Renal tubular acidosis (HP:0001947) | 2.08207289 |
| 109 | Cone-rod dystrophy (HP:0000548) | 2.06730938 |
| 110 | Epidermoid cyst (HP:0200040) | 2.06645423 |
| 111 | Cerebral palsy (HP:0100021) | 2.04607932 |
| 112 | Pancreatitis (HP:0001733) | 2.04376373 |
| 113 | Complement deficiency (HP:0004431) | 2.04349338 |
| 114 | Ventricular fibrillation (HP:0001663) | 2.04013090 |
| 115 | Abnormal hand bone ossification (HP:0010660) | 2.03340540 |
| 116 | Wide cranial sutures (HP:0010537) | 2.03016919 |
| 117 | Hypercholesterolemia (HP:0003124) | 2.00926425 |
| 118 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.00901161 |
| 119 | Increased mean platelet volume (HP:0011877) | 2.00202301 |
| 120 | Dicarboxylic aciduria (HP:0003215) | 1.99635837 |
| 121 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.99635837 |
| 122 | Myopathic facies (HP:0002058) | 1.99267771 |
| 123 | Curly hair (HP:0002212) | 1.98665303 |
| 124 | Nephritis (HP:0000123) | 1.98246279 |
| 125 | Flat capital femoral epiphysis (HP:0003370) | 1.97975147 |
| 126 | Abnormality of the 2nd finger (HP:0004100) | 1.97768764 |
| 127 | Ureteral stenosis (HP:0000071) | 1.96431981 |
| 128 | Alopecia of scalp (HP:0002293) | 1.96125878 |
| 129 | Thin bony cortex (HP:0002753) | 1.95056619 |
| 130 | Hyperphosphaturia (HP:0003109) | 1.93529046 |
| 131 | Abnormality of magnesium homeostasis (HP:0004921) | 1.92707659 |
| 132 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.92611412 |
| 133 | Fragile skin (HP:0001030) | 1.92046484 |
| 134 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.91684684 |
| 135 | Plantar hyperkeratosis (HP:0007556) | 1.90415425 |
| 136 | Abnormal vertebral ossification (HP:0100569) | 1.90375095 |
| 137 | Growth hormone excess (HP:0000845) | 1.90120598 |
| 138 | Abnormality of purine metabolism (HP:0004352) | 1.89483189 |
| 139 | Male infertility (HP:0003251) | 1.89464608 |
| 140 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.87749916 |
| 141 | Atrophic scars (HP:0001075) | 1.87711302 |
| 142 | Glomerulosclerosis (HP:0000096) | 1.86485896 |
| 143 | Abnormal ossification of hand bones (HP:0005921) | 1.86463443 |
| 144 | Goiter (HP:0000853) | 1.84825732 |
| 145 | Multiple lipomas (HP:0001012) | 1.84617161 |
| 146 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.83580852 |
| 147 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.79738347 |
| 148 | Irritability (HP:0000737) | 1.77458801 |
| 149 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.76702781 |
| 150 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73489410 |
| 151 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73318760 |
| 152 | Symptomatic seizures (HP:0011145) | 1.72188924 |
| 153 | Hypokalemia (HP:0002900) | 1.72097343 |
| 154 | Hyperaldosteronism (HP:0000859) | 1.71086340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.55997440 |
| 2 | FRK | 6.05118348 |
| 3 | LMTK2 | 5.69587823 |
| 4 | MST4 | 4.84111579 |
| 5 | MST1R | 4.54366911 |
| 6 | TAOK3 | 4.03298215 |
| 7 | PRKG2 | 3.31539700 |
| 8 | NME1 | 3.03810862 |
| 9 | EPHB2 | 2.85901747 |
| 10 | MAP2K2 | 2.74651968 |
| 11 | RIPK1 | 2.70897967 |
| 12 | GRK6 | 2.65213389 |
| 13 | FGFR4 | 2.22464018 |
| 14 | PIK3CA | 2.15436762 |
| 15 | EPHA2 | 2.04916496 |
| 16 | PTK6 | 2.00639719 |
| 17 | MAP3K2 | 1.96513964 |
| 18 | TESK1 | 1.81205436 |
| 19 | MAP3K10 | 1.80688994 |
| 20 | AKT3 | 1.76423999 |
| 21 | NUAK1 | 1.71971796 |
| 22 | TYK2 | 1.71198692 |
| 23 | EPHA3 | 1.66331406 |
| 24 | OXSR1 | 1.62578152 |
| 25 | MET | 1.53473608 |
| 26 | MYLK | 1.51245337 |
| 27 | TAOK1 | 1.51042163 |
| 28 | MAP4K1 | 1.47302413 |
| 29 | PRPF4B | 1.36519944 |
| 30 | KSR2 | 1.36357024 |
| 31 | ERN1 | 1.34928016 |
| 32 | TNIK | 1.21953427 |
| 33 | STK24 | 1.15830637 |
| 34 | FGFR3 | 1.15628705 |
| 35 | DDR2 | 1.12455710 |
| 36 | MATK | 1.08162675 |
| 37 | MAP3K7 | 1.06180887 |
| 38 | STK10 | 1.01324373 |
| 39 | EPHA4 | 0.99286617 |
| 40 | RIPK4 | 0.99055497 |
| 41 | MAP2K1 | 0.97444004 |
| 42 | PTK2 | 0.97421062 |
| 43 | ICK | 0.96675843 |
| 44 | PRKCI | 0.95002659 |
| 45 | ERBB2 | 0.92718735 |
| 46 | MAP3K9 | 0.92318184 |
| 47 | MAP3K8 | 0.87677278 |
| 48 | NLK | 0.85087299 |
| 49 | DMPK | 0.82777220 |
| 50 | TESK2 | 0.80126633 |
| 51 | FER | 0.79052627 |
| 52 | TTK | 0.78804729 |
| 53 | PAK4 | 0.78530573 |
| 54 | PRKAA2 | 0.76898592 |
| 55 | MAP2K6 | 0.74170264 |
| 56 | LATS1 | 0.72280096 |
| 57 | EPHB1 | 0.66980779 |
| 58 | MAP3K1 | 0.65447496 |
| 59 | LIMK1 | 0.63012884 |
| 60 | MAP3K11 | 0.60493198 |
| 61 | MAPK11 | 0.60211583 |
| 62 | IRAK1 | 0.58638318 |
| 63 | MAP3K12 | 0.57293644 |
| 64 | BMX | 0.56123693 |
| 65 | ERBB4 | 0.55923313 |
| 66 | JAK1 | 0.55395435 |
| 67 | CAMK2D | 0.53700681 |
| 68 | PIM1 | 0.51803802 |
| 69 | RET | 0.51753401 |
| 70 | PRKCZ | 0.51199929 |
| 71 | TRIB3 | 0.50956363 |
| 72 | BMPR2 | 0.50113645 |
| 73 | PDPK1 | 0.49052014 |
| 74 | PRKAA1 | 0.45830543 |
| 75 | JAK2 | 0.44891349 |
| 76 | YES1 | 0.44730736 |
| 77 | IKBKE | 0.44377706 |
| 78 | CSF1R | 0.44197465 |
| 79 | ZAP70 | 0.42491174 |
| 80 | PDK2 | 0.40894239 |
| 81 | SMG1 | 0.40544259 |
| 82 | AURKB | 0.39369611 |
| 83 | MAP3K14 | 0.39219575 |
| 84 | CSK | 0.38977205 |
| 85 | CDK19 | 0.38397221 |
| 86 | PAK1 | 0.38173027 |
| 87 | ABL2 | 0.37682450 |
| 88 | CASK | 0.37520680 |
| 89 | ARAF | 0.36105544 |
| 90 | SCYL2 | 0.36010017 |
| 91 | PAK3 | 0.34818009 |
| 92 | PDK1 | 0.34152643 |
| 93 | CDK6 | 0.33791995 |
| 94 | EEF2K | 0.33297250 |
| 95 | DYRK1B | 0.32566715 |
| 96 | PDK4 | 0.31982127 |
| 97 | PDK3 | 0.31982127 |
| 98 | SRC | 0.31605403 |
| 99 | STK39 | 0.31437525 |
| 100 | JAK3 | 0.31435555 |
| 101 | ROCK1 | 0.31350736 |
| 102 | CAMK2G | 0.31150476 |
| 103 | BTK | 0.31013423 |
| 104 | SYK | 0.30755473 |
| 105 | PRKCA | 0.30290574 |
| 106 | TBK1 | 0.30255904 |
| 107 | GRK1 | 0.29305177 |
| 108 | LRRK2 | 0.28617810 |
| 109 | CAMK2B | 0.27164592 |
| 110 | PBK | 0.26217076 |
| 111 | LYN | 0.26155953 |
| 112 | MELK | 0.24841038 |
| 113 | CSNK1A1 | 0.24389927 |
| 114 | IRAK4 | 0.23601907 |
| 115 | NEK6 | 0.23577276 |
| 116 | ITK | 0.23475964 |
| 117 | RPS6KA2 | 0.23296432 |
| 118 | PIM2 | 0.23032117 |
| 119 | KIT | 0.22723648 |
| 120 | MAP3K3 | 0.22283083 |
| 121 | STK11 | 0.21800134 |
| 122 | LCK | 0.21612207 |
| 123 | PAK2 | 0.21549497 |
| 124 | MAPKAPK2 | 0.20230649 |
| 125 | RPS6KB2 | 0.19872670 |
| 126 | WNK4 | 0.18508824 |
| 127 | PRKACG | 0.18507350 |
| 128 | CDC42BPA | 0.17657892 |
| 129 | STK3 | 0.17133836 |
| 130 | PRKCQ | 0.16835190 |
| 131 | FYN | 0.16678136 |
| 132 | PKN2 | 0.15634000 |
| 133 | CDK12 | 0.15184239 |
| 134 | BRAF | 0.14467266 |
| 135 | PDGFRA | 0.14160797 |
| 136 | AKT2 | 0.13605006 |
| 137 | FGR | 0.12096292 |
| 138 | NEK1 | 0.11577409 |
| 139 | PRKCD | 0.11175567 |
| 140 | MAP3K13 | 0.10470042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.54852639 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.88934322 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 4.33171714 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.00122215 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.98928360 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.18014495 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 2.85215786 |
| 8 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.58255015 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.54210811 |
| 10 | Bile secretion_Homo sapiens_hsa04976 | 2.41674205 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.30517077 |
| 12 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.06662706 |
| 13 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.05717101 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.02247900 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.98903131 |
| 16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.95099539 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.88238265 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77021098 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71875937 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.70792581 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.54557967 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30778619 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.25217290 |
| 24 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.23670127 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.22673007 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17687644 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07838801 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07813642 |
| 29 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.07394918 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06939324 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04850973 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98910007 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97866668 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.96252338 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.95804711 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 0.93805617 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 0.93057734 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91125505 |
| 39 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90026955 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88968352 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88622810 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87167640 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.85528094 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83011020 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80999991 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80188980 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78873646 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.78463073 |
| 49 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77686468 |
| 50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76818965 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73509225 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72864700 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70811595 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68610136 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64987702 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64438678 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63406635 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62245705 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.61310046 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61161652 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60447952 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59386852 |
| 63 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57358206 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56944056 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.52251074 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51826533 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49928352 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49298685 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49246737 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45604169 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.45407685 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44918368 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44786347 |
| 74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44617530 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.43394768 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.43275016 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42013602 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41080375 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.39657546 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38809670 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35857981 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.35426626 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35141564 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35132385 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34820140 |
| 86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34542077 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34064932 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.33249216 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31520519 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31416994 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.26884845 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26080783 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25345053 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23685405 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.23503383 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.23037809 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.22357829 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.22135334 |
| 99 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.21977813 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21921237 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.19949307 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.19499682 |
| 103 | Insulin secretion_Homo sapiens_hsa04911 | 0.19234652 |
| 104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.18814632 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.18647672 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18511914 |
| 107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.17504753 |
| 108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.17217191 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16753033 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.15777255 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14906670 |
| 112 | Renin secretion_Homo sapiens_hsa04924 | 0.14887044 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14845330 |
| 114 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.13414978 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12754265 |
| 116 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.11648949 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.09726560 |
| 118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.09337624 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.09203660 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.09147135 |
| 121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.09024424 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.06067437 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.05565513 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.05447354 |
| 125 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.04802760 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.04709655 |
| 127 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.04660256 |
| 128 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.04481751 |
| 129 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.04426340 |
| 130 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.04185823 |
| 131 | Gap junction_Homo sapiens_hsa04540 | 0.04018131 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.03542640 |

